logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
Y

Yasuo Miyoshi

Minoh City Hospital

60H指数
406论文数
1.8W被引数
收录论文 139
发表时间
logo
Preoperative muscle quality and postoperative computed tomography-defined muscle loss predict prognosis after gastrectomy for gastric cancer术前肌肉质量和术后计算机断层扫描定义的肌肉流失可预测胃癌胃切除术后预后
errClinical Nutrition ESPEN
IF2.6
err2026-09-21
err0
PREAI
errShinya Urakawa; Takafumi Hirao; Fuko Moriwaki; Keisuke Oyama; Masaya Higashiguchi; Masatoshi Nomura; Kaori Abe; Tadafumi Fukata; Kozo Noguchi; Katsuki Danno; Shigeru Nakane; Eriko Konishi; Yasuo Miyoshi; Mitsugu Sekimoto; Yoshio Oka
err分享
err收藏
E7389-LF as a first-line chemotherapy for patients with metastatic/advanced HER2-negative breast cancer: results from the phase 1 dose-expansion part of study 114E7389-LF作为HER2阴性转移性/晚期乳腺癌患者的一线化疗方案：研究114第1期剂量扩展部分的结果
errBreast Cancer Research
IF5.6
err2026-09-17
err0
errOAAI
errHiroshi Ishiguro; Yasuo Miyoshi; Hiroyuki Yasojima; Junichiro Watanabe; Toshimi Takano; Akihiko Shimomura; Eriko Tokunaga; Toru Mukohara; Yasuto Naoi; Daiko Matsuoka; Shiori Okumura; Yohei Otake; Takuya Suzuki; Takao Takase; Taro Semba; Ziming Zhao; Kan Yonemori
err分享
err收藏
Identifying immune-related predictive factors for post-eribulin therapy in patients with HER2-negative advanced breast cancer- a multicenter retrospective study
errInternational Journal of Clinical Oncology
IF2.8
err2026-01-31
err0
PREAI
errYuri Takamatsu; Yoshiya Horimoto; Yasuo Miyoshi; Junichiro Watanabe; Goro Kutomi
err分享
err收藏
Pembrolizumab for Early-Stage Triple-Negative Breast Cancer: KEYNOTE-522 Japan Subgroup Analysis
errCancer Science
IF4.3
err2026-01-14
err0
errOAAI
errMasato Takahashi; Hirofumi Mukai; Toshimi Takano; Koichiro Tsugawa; Kenichi Inoue; Mitsuya Itoh; Junichiro Watanabe; Yuko Tanabe; Naohito Yamamoto; Yasuo Miyoshi; Kenichi Watanabe; Toru Mukohara; Yibin Kong; Masashi Shimura; Francisco Beca; Peter Schmid; Hiroji Iwata
err分享
err收藏
Targeting Interleukin-6 as a Novel Strategy to Overcome Eribulin Resistance in Breast Cancer将白介素-6作为克服乳腺癌中艾瑞布林耐药性的新型策略
errCancer Medicine
IF3.1
err2025-11-04
err0
errOAAI
errAkira Hattori; Masayuki Nagahashi; Miki Komatsu; Sayaka Urano; Mamiko Kuroiwa; Yosuke Matsushita; Toyomasa Katagiri; Masafumi Shimoda; Yasuo Miyoshi
err分享
err收藏
Olanzapine for nausea and vomiting in people with breast cancer treated with trastuzumab deruxtecan: plain language summary of the ERICA study奥氮平用于接受曲妥珠单抗德鲁克替康治疗的乳腺癌患者的恶心和呕吐：ERICA研究的简明语言摘要
errFuture Oncology
IF2.6
err2025-10-24
err0
errOAAI
errHitomi Sakai; Junji Tsurutani; Yukinori Ozaki; Hiroshi Ishiguro; Kazuki Nozawa; Takashi Yamanaka; Kenjiro Aogi; Koji Matsumoto; Tsutomu Iwasa; Mariko Tokiwa; Michiko Tsuneizumi; Yasuo Miyoshi; Chiyoe Kitagawa; Mitsugu Yamamoto; Yuko Takano; Chiyo K. Imamura; Yasutaka Chiba; Daisuke Takiguchi; Takayuki Ezumi; Toshimi Takano
err分享
err收藏
Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecan曲妥珠单抗-美坦新偶联物和曲妥珠单抗-德鲁替康治疗晚期乳腺癌患者的外周血生物标志物的临床意义
errinternational journal of oncology
IF2.8
err2025-04-29
err0
errOAAI
errTogashi, Yusa; Nagahashi, Masayuki; Oshiro, Aoi; Sugimoto, Gen; Mitsuyoshi, Ayumu; Kanaoka, Haruka; Hattori, Akira; Tsuchida, Junko; Higuchi, Tomoko; Nishimukai, Arisa; Miyoshi, Yasuo
err分享
err收藏
Development and internal validation of a predictive model of overall and progression-free survival in eribulin-treated patients with breast cancer based on baseline peripheral blood parameters
errBREAST CANCER
IF2.9
err2025-02-20
err0
errOAAI
errNatori, Keiko; Igeta, Masataka; Morimoto, Takashi; Nagahashi, Masayuki; Akashi-Tanaka, Sadako; Daimon, Takashi; Miyoshi, Yasuo
err分享
err收藏
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy
errBREAST CANCER
IF2.9
err2025-01-14
err0
errOAAI
errNagahashi, Masayuki; Ishikawa, Eri; Nagai, Takahiro; Kanaoka, Haruka; Oshiro, Aoi; Togashi, Yusa; Hattori, Akira; Tsuchida, Junko; Higuchi, Tomoko; Nishimukai, Arisa; Murase, Keiko; Takatsuka, Yuichi; Kihara, Takako; Ling, Yiwei; Okuda, Shujiro; Hirota, Seiichi; Miyoshi, Yasuo
err分享
err收藏
Nuclear PD-L1 triggers tumour-associated inflammation upon DNA damage
errEMBO REPORTS
IF6.2
err2025-01-02
err0
errOAAI
errNihira, Naoe T.; Wu, Wenwen; Hosoi, Mitsue; Togashi, Yukiko; Sunada, Shigeaki; Miyoshi, Yasuo; Miki, Yoshio; Ohta, Tomohiko
err分享
err收藏
Ribosomal S6 kinase (RSK) plays a critical role in DNA damage response via the phosphorylation of histone lysine demethylase KDM4B
errBREAST CANCER RESEARCH
IF5.6
err2024-10-21
err1
errOAAI
errWu, Wenwen; Zhu, Jing; Nihira, Naoe Taira; Togashi, Yukiko; Goda, Atsushi; Koike, Junki; Yamaguchi, Kiyoshi; Furukawa, Yoichi; Tomita, Takuya; Saeki, Yasushi; Johmura, Yoshikazu; Nakanishi, Makoto; Miyoshi, Yasuo; Ohta, Tomohiko
err分享
err收藏
Targeting S1P signaling pathway in triple-negative breast cancer with TP53 mutations
errANNALS OF ONCOLOGY
IF65.4
err2024-10-01
err0
PREAI
errNagahashi, M.; Komatsu, M.; Urano, S.; Kuroiwa, M.; Miyoshi, Y.
err分享
err收藏
Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial)
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2024-06-26
err0
PREAI
errIwamoto, Takayuki; Niikura, Naoki; Watanabe, Kenichi; Takeshita, Takashi; Kikawa, Yuichiro; Kobayashi, Kokoro; Iwakuma, Nobutaka; Okamura, Takuho; Kobayashi, Takayuki; Katagiri, Yuriko; Kitada, Masahiro; Tomioka, Nobumoto; Miyoshi, Yasuo; Shigematsu, Hideo; Miyashita, Minoru; Ishiguro, Hiroshi; Masuda, Norikazu; Saji, Shigehira
err分享
err收藏
The role of sphingolipids in cancer progression and its microenvironment in breast cancer patients
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errHattori, Akira; Nagahashi, Masayuki; Oshiro, Aoi; Mitsuyoshi, Ayumu; Kanaoka, Haruka; Bun, Ayako; Fukui, Reiko; Fujimoto, Yukie; Higuchi, Tomoko; Nishimukai, Arisa; Murase, Keiko; Takatsuka, Yuichi; Miyoshi, Yasuo
err分享
err收藏
Pembrolizumab plus Olaparib vs Pembrolizumab plus Chemotherapy After Induction With Pembrolizumab plus Chemotherapy for Locally Recurrent Inoperable or Metastatic TNBC: Randomized Open-Label Phase 2 KEYLYNK-009 Study
errCANCER RESEARCH
IF16.6
err2024-05-02
err2
PREAI
errRugo, Hope; Robson, Mark; Im, Seock-Ah; Dalenc, Florence; Ruiz, Eduardo Yanez; Im, Young-Hyuck; Kulyk, Sergii; Dudnichenko, Oleksandr; Llinas-Quintero, Nestor; Saji, Shigehira; Miyoshi, Yasuo; Harbeck, Nadia; Fan, Li; Mejia, Jaime; Karantza, Vassiliki; Cescon, David
err分享
err收藏
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan
errBREAST CANCER
IF2.9
err2024-03-07
err0
PREAI
errTsuchida, Yasue; Niikura, Naoki; Chishima, Takashi; Mizuno, Mari; Kawate, Takahiko; Fuchikami, Hiromi; Miyoshi, Yasuo; Sakai, Takehiko; Kotani, Haruru; Kondo, Naoto; Hayashi, Naoki
err分享
err收藏
Reply to comment on 'An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers' by Fukui et al.
errBREAST CANCER
IF2.9
err2024-03-04
err0
PREAI
errFukui, Reiko; Watanabe, Takahiro; Morimoto, Koji; Fujimoto, Yukie; Nagahashi, Masayuki; Ishikawa, Eri; Hirota, Seiichi; Miyoshi, Yasuo
err分享
err收藏
Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B)
errBREAST
IF7.9
err2023-10-01
err4
errOAAI
errMasuda, Hiroko; Tanabe, Yuko; Sakai, Hitomi; Matsumoto, Koji; Shimomura, Akihiko; Doi, Mihoko; Miyoshi, Yasuo; Takahashi, Masato; Sagara, Yasuaki; Tokunaga, Shinya; Iwasa, Tsutomu; Niikura, Naoki; Yoshimura, Kenichi; Takano, Toshimi; Tsurutani, Junji
err分享
err收藏
Baseline interleukin-6 is a prognostic factor for patients with metastatic breast cancer treated with eribulin
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2023-09-21
err2
errOAAI
errBun, Ayako; Nagahashi, Masayuki; Kuroiwa, Mamiko; Komatsu, Miki; Miyoshi, Yasuo
err分享
err收藏
Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer
errANNALS OF SURGERY
IF6.4
err2023-06-15
err15
errOAAI
errWu, Rongrong; Oshi, Masanori; Asaoka, Mariko; Yan, Li; Benesch, Matthew G. K.; Khoury, Thaer; Nagahashi, Masayuki; Miyoshi, Yasuo; Endo, Itaru; Ishikawa, Takashi; Takabe, Kazuaki
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
L
Lloyd J. Old
H 指数: 155 · 论文数: 961
F
Fabrice André
H 指数: 148 · 论文数: 1.8K
H
Hope S. Rugo
H 指数: 137 · 论文数: 1.6K
N
Nadia Harbeck
H 指数: 131 · 论文数: 2.1K
K
Keiji Tanaka
H 指数: 127 · 论文数: 554
查看更多